Newer lung cancer treatments extend survival longer than traditional regimens

Patients with advanced non-small cell lung cancer who are treated with regimens containing paclitaxel and carboplatin survive longer than patients treated with older cisplatin-based regimens or supportive care, a new study finds.

"While advanced lung cancer remains incurable, this study provides additional evidence that paclitaxel- and carboplatin-based regimens can prolong survival of patients with this disease," said John Hainsworth, MD, lead study author and Director of Clinical Research at the Sarah Cannon Cancer Center. "Survival beyond two years has been uncommon with previous treatments for advanced non-small cell lung cancer. With these newer regimens, two-year survival is similar to what we used to see at one year with the best supportive care or older regimens."

This study provides long-term follow-up on 321 patients with newly-diagnosed stage IIIB or IV non-small cell lung cancer who were treated in one of three sequential phase II trials between March 1995 and April 1998. All three trials were conducted in The Minnie Pearl Cancer Research Network, a community-based clinical trials group. Each trial included a different treatment regimen: paclitaxel and carboplatin; paclitaxel, carboplatin and gemcitabine; and paclitaxel, carboplatin, and vinorelbine. Data from these trials were compared retrospectively to previous studies on supportive care or traditional cisplatin-based regimens.

After an average follow-up of 58 months, actual one-, two-, and three-year survival rates were 40 percent, 19 percent, and 7 percent, respectively. The actuarial four-year survival rate for the entire group was four percent.

When compared retrospectively to older cisplatin-based regimens (not containing a taxane), these paclitaxel- and carboplatin-based treatments increase one-year survival from 25 to 30 percent, to 35 to 40 percent. These regimens also improve survival substantially when compared to the 16 percent one-year survival rate

Contact: Stacia Momburg
American Society of Clinical Oncology

Page: 1 2

Related medicine news :

1. Newer formulation of heparin improves outcomes for suspected heart attack patients
2. Newer rheumatoid arthritis drugs: Harmful on the liver?
3. Newer vitamin D formulation appears to help dialysis patients live longer
4. Newer form of gold standard drug helps kidney transplant patients do better in long term
5. Physicians Slow To Adopt Newer Drugs For Atrial Fibrillation
6. Hormonal treatment improves survival in high-risk prostate cancer patients
7. International breast cancer prevention study launches in the United States and Canada
8. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
9. Cultural and social factors influence prostate cancer treatment
10. Primary care office strategies may increase colon cancer screening
11. Benefits of lung cancer screening with CT questioned

Post Your Comments:

(Date:8/15/2019)... ... August 15, 2019 , ... The ASCP Foundation ... been directly affected by the closure of Hahnemann University Hospital in Philadelphia, which ... campaign, the ASCP Foundation will be making hardship grants of up to $2,500 ...
(Date:8/15/2019)... ... 15, 2019 , ... Jon O'Brien, president of Catholics for ... to provide written assurance that they will comply with the Trump Administration’s domestic ... Rule, the new policy restricts providers and clinics that receive federal Title X ...
(Date:8/14/2019)... ... ... Teguar Corporation has claimed the #3719 position on the Inc. 5000 list ... mark of success for some of Americas top companies and has famously been occupied ... 2016 and 2017. This year, Teguar secured a spot on the list for a ...
(Date:8/14/2019)... ... August 14, 2019 , ... ScribeAmerica, the nation’s most ... a place on the Inc. magazine 500/5000 list today for the ninth consecutive ... of ScribeAmerica’s recognition as one of the fastest growing companies in America. ...
(Date:8/14/2019)... ... ... New Hampshire-based Vera Roasting Company , makers of the only CBD ... of CBD-infused coffees with the release of a new higher-dosage organic Wellness Blend ... are excited to expand our CBD-infused product lines to include a more potent CBD ...
Breaking Medicine News(10 mins):
(Date:8/12/2019)... ... , ... Intalere, the healthcare industry leader in delivering optimal cost, quality and ... of The Year - Health IT category of the Pittsburgh Technology Center (PTC) 2019 ... Center as a healthcare IT innovator in the Pittsburgh area,” said Julius Heil, President ...
(Date:8/10/2019)... ... August 10, 2019 , ... Founder Margie Barilla ... parents to obtain mental health screenings for early onset of depression, suicidal ideation, ... a solution to the community with free assessment reviews. At scheduled assessments students ...
(Date:8/9/2019)... ... August 09, 2019 , ... Worldwide Business with kathy ireland® ... Yu to discuss their revolutionary, game-changing technology that catches cancer early. , ... a novel technology based on the biophysical properties of the cell, which can ...
Breaking Medicine Technology:
Cached News: